Lemaitre Vascular (LMAT)
NASDAQ:LMAT

Lemaitre Vascular (LMAT) Stock Forecast & Price Target

164 Followers
See the Price Targets and Ratings of:

LMAT Analyst Ratings

Hold
2Ratings
0 Buy
2 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Lemaitre
Vascular
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LMAT Stock 12 Months Forecast

Average Price Target

$46.00
▼(-2.48% Downside)
Based on 2 Wall Street analysts offering 12 month price targets for Lemaitre Vascular in the last 3 months. The average price target is $46.00 with a high forecast of $46.00 and a low forecast of $46.00. The average price target represents a -2.48% change from the last price of $47.17.
Highest Price Target$46.00Average Price Target$46.00Lowest Price Target$46.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

LMAT Financial Forecast

LMAT Earnings Forecast
Next quarter’s earnings estimate for LMAT is $0.26 with a range of $0.24 to $0.27. The previous quarter’s EPS was $0.25. LMAT beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.42% of the time in the same period. In the last calendar year LMAT has Underperformed its overall industry.
Next quarter’s earnings estimate for LMAT is $0.26 with a range of $0.24 to $0.27. The previous quarter’s EPS was $0.25. LMAT beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.42% of the time in the same period. In the last calendar year LMAT has Underperformed its overall industry.
LMAT Sales Forecast
Next quarter’s sales forecast for LMAT is $41.00M with a range of $40.00M to $41.48M. The previous quarter’s sales results were $39.03M. LMAT beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 42.88% of the time in the same period. In the last calendar year LMAT has Outperformed its overall industry.
Next quarter’s sales forecast for LMAT is $41.00M with a range of $40.00M to $41.48M. The previous quarter’s sales results were $39.03M. LMAT beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 42.88% of the time in the same period. In the last calendar year LMAT has Outperformed its overall industry.
LMAT Analyst Recommendation Trends
In the current month, LMAT has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LMAT average analyst price target in the past 3 months is $46.00
In the current month, LMAT has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LMAT average analyst price target in the past 3 months is $46.00

LMAT Stock Forecast FAQ

What is LMAT’s average 12-month price target, according to analysts?
Based on analyst ratings, Lemaitre Vascular’s 12-month average price target is $46.00.
    What is LMAT’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for LMAT, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is LMAT a Buy, Sell or Hold?
        Lemaitre Vascular has a conensus rating of Hold which is based on 0 buy ratings, 2 hold ratings and 0 sell ratings.
          What is Lemaitre Vascular’s price target?
          The average price target for Lemaitre Vascular is $46.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $46.00 ,the lowest forecast is $46.00. The average price target represents -2.48% Decrease from the current price of $47.17.
            What do analysts say about Lemaitre Vascular?
            Lemaitre Vascular’s analyst rating consensus is a ‘Hold. This is based on the ratings of 2 Wall Streets Analysts.

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis